Ramezani-Moghadam, M., Wang, J., Brymora, J., George, J., and Hebbard, L. (2010) Adiponectin's anti-fibrogenic action on hepatic stellate cells: stimulation of TIMP-1 and the mediation of HSC apoptosis, proliferation and invasion. Journal of Gastroenterology and Hepatology, 25 (Suppl. 3). A3-A3.

PDF (Abstract Only) - Published Version Restricted to Repository staff only

Abstract

Adiponectin (ADN), an adipocytokine with anti-inflammatory, anti-atherogenic and insulin sensitising properties induces an anti-fibrogenic HSC profile in vitro. ADN has been previously reported by us to inhibit proliferation, migration and to induce apoptosis in activated HSCs. Adiponectin binds to the AdipoR1 and -R2 receptors and signals through the AMP- activated protein kinase (AMPK). We find that adiponectin through AMPK stimulates HSCs to release the matrix metalloproteinase inhibitor, TIMP-1. Traditionally, TIMP-1 has been associated with the progression of liver fibrosis. Thus, the induction of TIMP-1 by adiponectin would appear to be counter-intuitive to its published anti-fibrotic effects. Therefore, the aim of this study was to determine the functional significance of adiponectin-stimulated TIMP-1 on activated HSCs and their role in liver fibrosis.

Methods: Activated primary rat HSCs were treated with ADN for between 4 and 48 h. To determine the signalling pathways that mediate ADN’s stimulation of TIMP-1, cells were treated with the AMPK antagonists, Compound C or AraA. HSC proliferation and apoptosis was assessed by BrdU incorporation and Annexin V binding (FACS), respectively. TIMP-1 protein levels were determined by ELISA and HSC invasion assays were conducted according to a modified migration assay using transwell membranes (Boyden chambers) coated with rat tail collagen I.

Results: ADN treatment for 4–48 h resulted in approximately a threefold increase in TIMP-1 levels. The application of ADN for 24 h concurrently with Compound C or AraA reduced TIMP-1 levels. Treatment of activated HSCs with ADN for 48 h resulted in a 20% increase in apoptosis as measured by Annexin V binding and a 50% reduction in proliferation. Concurrent treatment of ADN with a TIMP-1 blocking antibody resulted in a further 30% increase in Annexin V binding and a further reduction in proliferation. Furthermore, ADN treatment of activated HSCs resulted in a 50% reduction in invasion. Similarly, the concurrent treatment of ADN with a TIMP-1 blocking antibody reversed the inhibitory effects of ADN on HSC invasion.

Conclusion: Adiponectin stimulates TIMP-1 levels in activated HSCs through an AMPK-dependent mechanism. TIMP-1 mediates ADN- associated reductions in HSC invasion and modulates its effects on HSC apoptosis and proliferation. These data suggest novel roles for TIMP-1 in the context of liver fibrosis. We are now exploring the association of adiponectin and TIMP-1 in mouse models of liver fibrosis.

Item ID:	86246
Item Type:	Article (Abstract)
ISSN:	1440-1746
Copyright Information:	© 2010 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.
Date Deposited:	01 Sep 2026 05:29
FoR Codes:	32 BIOMEDICAL AND CLINICAL SCIENCES > 3202 Clinical sciences > 320209 Gastroenterology and hepatology @ 100%
SEO Codes:	20 HEALTH > 2001 Clinical health > 200101 Diagnosis of human diseases and conditions @ 100%
	More Statistics